No instruction has been issued to general practitioners requiring them to reduce the availability of prescribed drugs to medical card holders.
In the course of the 1990-91 review of the GMS contract, it was agreed between the Irish Medical Organisation and management that, as part of a co-ordinated drugs strategy, indicative prescribing budgets would be determined for all doctors in the GMS scheme. It was further agreed that these budgets would be based on the best information available and that they would be refined and adjusted annually. This process has now commenced and indicative figures were circulated to doctors for a six month period this year, prior to the circulation of the annual targets for 1992 which will be determined following discussion with the Irish Medical Organisation.
The cost of prescribing in the GMS has risen from £79.5 million in 1986 to an estimated £118 million in 1991.
In general, the 1992 target figures for individual practices will take account of the total amount available for the GMS and standard costs having regard to panel size and demography.
I stress that the target figures will not interfere with the right of doctors to prescribe as they consider necessary but will allow them to objectively assess their overall prescribing levels with comparable practices.